Table of Contents Author Guidelines Submit a Manuscript
Sleep Disorders
Volume 2012, Article ID 308952, 8 pages
http://dx.doi.org/10.1155/2012/308952
Clinical Study

An Investigation into the Use of Stimulant Therapy during Pregnancy

1School of Medicine, King’s College London, London WC2R 2LS, UK
2Sleep Disorders Centre, St Thomas’ Hospital, London SE1 7EH, UK

Received 22 November 2011; Revised 25 March 2012; Accepted 6 May 2012

Academic Editor: Liborio Parrino

Copyright © 2012 Natalie Shields et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. E. Scammell , “The neurobiology, diagnosis, and treatment of narcolepsy,” Annals of Neurology, vol. 53, no. 2, pp. 154–166, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. American Academy of Sleep Medicine, Diagnostic and Coding Manual. International Classifciation of Sleep Disorders, AASM, Westchester, NY, USA, 2nd edition, 2005.
  3. American Academy of Sleep Medicine, “Practice parameters for the use of stimulants in the treatment of narcolepsy. Standards of Practice Committee of the American Sleep Disorders Association,” Sleep, vol. 17, pp. 348–351, 1994. View at Google Scholar
  4. E. Mignot, “Narcolepsy: pharmacology, pathophysiology, and genetics,” in Principles and Practices of Sleep Medicine, M. H. Kryger, T. Roth, and W. C. Dement, Eds., pp. 761–779, Elselvier, Philidelphia, Pa, USA, 4th edition, 2005. View at Google Scholar
  5. C. Guilleminault and V. Abad, “Narcolepsy,” in Sleep Disorders Medicine, S. Chokeroverty, Ed., pp. 377–396, Saunder Elsevier, Philidelphia, Pa, USA, 3rd edition, 2009. View at Google Scholar
  6. Food and Drug Administration, USA. FDA Pregnancy Categories, http://depts.washington.edu/druginfo/Formulary/Pregnancy.pdf.
  7. T. I. Morgenthaler, V. K. Kapur, T. Brown et al., “Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin: an American Academy of Sleep Medicine report,” Sleep, vol. 30, no. 12, pp. 1705–1711, 2007. View at Google Scholar · View at Scopus
  8. National Toxicological Program Centre for the Evaluation of Risks to Human Reproduction. Monograph on the potential human reproductive and developmental effects of methyphenidate, 2005, http://cerhr.niehs.nih.gov/evals/stimulants/methylphenidate/MethylphenidateMonograph.pdf.
  9. National Toxicological Program Centre for the Evaluation of Risks to Human Reproduction. Monograph on the potential human reproductive and developmental effects of amphetamines, 2005, http://cerhr.niehs.nih.gov/evals/stimulants/amphetamines/AmphetamineMonograph.pdf.
  10. National Teratology Information Service. Use of methylphenidate in pregnancy, 2008, http://www.toxbase.org.
  11. G. Briggs, R. Freeman, and S. Yaffe, Drugs in Pregnancy and Lactation, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 7th edition, 2005.
  12. M. Mitler and M. O’Malley, “Wake-promoting medications: efficacy and adverse effects,” in Principles and Practices of Sleep Medicine, M. H. Kryger, T. Roth, and W. C. Dement, Eds., pp. 484–450, Elselvier, Philidelphia, Pa, USA, 4th edition, 2005. View at Google Scholar
  13. R. Hoque and A. L. Chesson, “Conception, pregnancy, delivery, and breastfeeding in a narcoleptic patient with cataplexy,” Journal of Clinical Sleep Medicine, vol. 4, no. 6, pp. 601–603, 2008. View at Google Scholar · View at Scopus
  14. C. Guilleminault and S. Fromherz, “Narcolepsy: diagnosis and Management,” in Principles and Practices of Sleep Medicine, M. H. Kryger, T. Roth, and W. C. Dement, Eds., pp. 780–790, Elselvier, Philidelphia, Pa, USA, 4th edition, 2005. View at Google Scholar